Use of the Delphi method to facilitate antithrombotics prescription during pregnancy.

INTRODUCTION Management of pregnant women at risk for venous thromboembolism (VTE) remains complex. Guidelines do not definitively fix optimal strategies due to limited trial data. Our objective was to build an easy-to-use tool allowing individualised, risk-adapted prophylaxis. MATERIALS AND METHODS A Delphi exercise was conducted to collect 19 French experts' opinions on pregnancy-related VTE. RESULTS Experts with an active interest in clinical research and care of VTE and placental vascular complications were selected. The risk score was classified by an anonymous computer vote. A scoring system for VTE risk in pregnant women was developed, each score being associated with a specific treatment: graduated elastic compression stockings, aspirin, prophylactic Low Molecular Weight Heparin (LMWH: variable durations), or adjusted-dose of LMWH through pregnancy and postpartum. CONCLUSIONS Our simple consensual scoring system offers an individual estimation of thrombosis risk during pregnancy together with its related therapeutic strategy, in accordance with most of the new international recommendations. The accuracy of our individual risk score-based therapeutic guidance is currently being prospectively evaluated in a multicenter trial.

[1]  C. Jégo,et al.  Low Molecular Weight Heparins , 2012, Drugs.

[2]  P. Godeau Conférence de consensus , 2000 .

[3]  B. Yawn,et al.  Risk factors for deep vein thrombosis and pulmonary embolism during pregnancy or post partum: a population-based, case-control study. , 2001, American journal of obstetrics and gynecology.

[4]  I. Greer,et al.  The role of inherited thrombophilia in venous thromboembolism associated with pregnancy , 1999, British journal of obstetrics and gynaecology.

[5]  M Greaves,et al.  Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study. , 2006, Health technology assessment.

[6]  L. Salmi,et al.  [Consensus methods: review of original methods and their main alternatives used in public health]. , 2008 .

[7]  D. Hunter,et al.  Qualitative Research: Consensus methods for medical and health services research , 1995 .

[8]  B. Brenner,et al.  Safety of Low-Molecular-Weight Heparin in Pregnancy: A Systematic Review , 1999, Thrombosis and Haemostasis.

[9]  R. Zotz,et al.  Effect of hemostatic risk factors on the individual probability of thrombosis during pregnancy and the puerperium , 2003, Thrombosis and Haemostasis.

[10]  P. Sandset,et al.  Ante‐ and postnatal risk factors of venous thrombosis: a hospital‐based case–control study , 2008, Journal of thrombosis and haemostasis : JTH.

[11]  J. Kujovich Thrombophilia and pregnancy complications. , 2004, American journal of obstetrics and gynecology.

[12]  Glenn Regehr,et al.  Delphi as a method to establish consensus for diagnostic criteria. , 2003, Journal of clinical epidemiology.

[13]  M. Stephenson,et al.  Low‐Molecular‐Weight Heparins in Pregnancy , 1999, Pharmacotherapy.

[14]  G. Leone,et al.  The risk of recurrent venous thromboembolism in pregnancy and puerperium without antithrombotic prophylaxis , 2006 .

[15]  E. Myers,et al.  Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality. , 2006, American journal of obstetrics and gynecology.

[16]  C. Négrier,et al.  Management of pregnant women with increased risk of venous thrombosis , 2005, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[17]  Louis-Rachid Salmi,et al.  Méthodes de consensus : revue des méthodes originales et de leurs grandes variantes utilisées en santé publique , 2008 .

[18]  N. Dalkey,et al.  An Experimental Application of the Delphi Method to the Use of Experts , 1963 .

[19]  F. Rosendaal,et al.  Increased fetal loss in women with heritable thrombophilia , 1996, The Lancet.

[20]  R. Zotz,et al.  Prediction, prevention, and treatment of venous thromboembolic disease in pregnancy. , 2003, Seminars in thrombosis and hemostasis.

[21]  N Jairath,et al.  The Delphi methodology (Part one): A useful administrative approach. , 1994, Canadian journal of nursing administration.

[22]  J. Hirsh,et al.  Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). , 2008, Chest.

[23]  I. Greer,et al.  Antenatal use of enoxaparin for prevention and treatment of thromboembolism in pregnancy , 2000, BJOG : an international journal of obstetrics and gynaecology.

[24]  A. Kaider,et al.  Preeclampsia and Fetal Loss in Women With a History of Venous Thromboembolism , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[25]  P. Gibson,et al.  Drugs in pregnancy. Anticoagulants. , 2001, Best practice & research. Clinical obstetrics & gynaecology.

[26]  A. Eldor The use of low-molecular-weight heparin for the management of venous thromboembolism in pregnancy. , 2002, European journal of obstetrics, gynecology, and reproductive biology.

[27]  L. Leape,et al.  Measuring the Necessity of Medical Procedures , 1994, Medical care.

[28]  S. Laporte,et al.  Feasibility of an easy-to-use risk score in the prevention of venous thromboembolism and placental vascular complications in pregnant women: a prospective cohort of 2736 women. , 2008, Thrombosis research.

[29]  D. Spiegelhalter,et al.  Consensus development methods, and their use in clinical guideline development. , 1998, Health technology assessment.

[30]  B. Dahlbäck,et al.  Individual risk assessment of thrombosis in pregnancy , 2002, Acta obstetricia et gynecologica Scandinavica.

[31]  A. Kaider,et al.  Risk of pregnancy‐associated recurrent venous thromboembolism in women with a history of venous thrombosis , 2005, Journal of thrombosis and haemostasis : JTH.

[32]  J. Bonnar,et al.  Can more be done in obstetric and gynecologic practice to reduce morbidity and mortality associated with venous thromboembolism? , 1999, American journal of obstetrics and gynecology.

[33]  A. Pastuszak,et al.  Drugs in pregnancy. , 1998, The New England journal of medicine.

[34]  J. Langhoff‐Roos,et al.  Inherited thrombophilias and adverse pregnancy outcome: screening and management. , 2005, Seminars in perinatology.

[35]  J. Gris,et al.  More on: factor V Leiden and prothrombin G20210A polymorphisms as risk factors for miscarriage during a first intended pregnancy: the matched case‐control ‘NOHA First’ study , 2006, Journal of thrombosis and haemostasis : JTH.

[36]  R H Brook,et al.  A Method for the Detailed Assessment of the Appropriateness of Medical Technologies , 1986, International Journal of Technology Assessment in Health Care.

[37]  P. Bernstein,et al.  Risk factor scoring for predicting venous thromboembolism in obstetric patients , 2000 .

[38]  C. Chauleur,et al.  Enquête sur la prévention de la maladie thromboembolique maternelle après la publication des Recommandations pour la pratique clinique (RPC) , 2008 .

[39]  A. James Prevention and management of venous thromboembolism in pregnancy. , 2007, The American journal of medicine.

[40]  J. Ray,et al.  Deep vein thrombosis during pregnancy and the puerperium: a meta-analysis of the period of risk and the leg of presentation. , 1999, Obstetrical & gynecological survey.

[41]  Jeffrey S. Ginsberg,et al.  Use of antithrombotic agents during pregnancy. , 1992, Chest.

[42]  J. Hirsh,et al.  Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. , 2004, Chest.

[43]  G. Leone,et al.  Prophylaxis and Treatment of Venous Thromboembolism in Individuals with Inherited Thrombophilia , 2006, Seminars in thrombosis and hemostasis.

[44]  M. Spannagl,et al.  Risk stratification and heparin prophylaxis to prevent venous thromboembolism in pregnant women , 2007, Thrombosis and Haemostasis.

[45]  I. Greer Prevention of venous thromboembolism in pregnancy. , 2003, European journal of medical research.

[46]  C A Lindeman,et al.  DELPHI SURVEY OF PRIORITIES IN CLINICAL NURSING RESEARCH , 1975, Nursing research.